tradingkey.logo

Intelligent Bio Solutions Inc

INBS
View Detailed Chart

1.320USD

-0.100-7.04%
Close 09/19, 16:00ETQuotes delayed by 15 min
9.67MMarket Cap
LossP/E TTM

Intelligent Bio Solutions Inc

1.320

-0.100-7.04%
Intraday
1m
30m
1h
D
W
M
D

Today

-7.04%

5 Days

-26.26%

1 Month

-9.59%

6 Months

-39.17%

Year to Date

-5.71%

1 Year

-26.46%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a . Despite an average stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
288 / 506
Overall Ranking
491 / 4720
Industry
Biotechnology & Medical Research

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
12.000
Target Price
+455.56%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 142.87% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 3.05M.
Fairly Valued
The company’s latest PE is -0.66, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 836.82K shares, increasing 14.75% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 15.48K shares of this stock.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.
Ticker SymbolINBS
CompanyIntelligent Bio Solutions Inc
CEOMr. Harry Simeonidis
Websitehttps://ibs.inc/
KeyAI